title: Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology.
abstract: Our aim was to collect a large number of cases to characterize clinical presentation, outcome, and prognosis of chronic intestinal pseusoobstruction in children. We conducted a retrospective multicenter study that included children treated for chronic intestinal pseusoobstruction defined as recurrent episodes of intestinal obstruction with no mechanical obstruction, excluding Hirschsprung's disease. In all, 105 children, 57 boys and 48 girls, were studied, including five familial forms. Prenatal diagnosis was made in 18 patients. Eighty patients were less than 12 months old at onset; the disease began at birth for 37 patients. The most frequent signs were abdominal distension, vomiting, and constipation. Megacystis was noted in myopathies (7 cases), neuropathies (10 cases) and unclassified forms (13 cases). For all but three cases (two patients with CMV infection, one with Munchhausen-by-proxy syndrome), the associated diseases and disorders could not account for chronic intestinal pseusoobstruction as a secondary disorder. At least one full-thickness biopsy from the digestive tract was studied for 99 patients. The diagnosis recorded was visceral neuropathy in 58 cases, visceral myopathy in 17 cases, and uncertain or normal biopsy results in 24 cases. Seventy-eight children were fed intravenously, and only 18 were able to be fed orally throughout their illness. Seventy-one patients underwent surgery during their illness, and 217 surgical procedures, a mean of 3 per patient, were performed. Ostomy was the most performed procedure. Follow-up continued in 89 patients for 3 months to 16 years (mean 85 months). Forty-two patients were still fed by parenteral (39 patients) or enteral nutrition (3 patients) at the time of the study. Eleven patients died between the age of 1 month and 14 years 7 months.
authors.affiliation: Service de Gastroentérologie Pédiatrique, Hôpital Robert Debré, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Faure
authors.forename: O
authors.initials: O
authors.lastname: Goulet
authors.forename: S
authors.initials: S
authors.lastname: Ategbo
authors.forename: A
authors.initials: A
authors.lastname: Breton
authors.forename: P
authors.initials: P
authors.lastname: Tounian
authors.forename: J L
authors.initials: JL
authors.lastname: Ginies
authors.forename: B
authors.initials: B
authors.lastname: Roquelaure
authors.forename: C
authors.initials: C
authors.lastname: Despres
authors.forename: M
authors.initials: M
authors.lastname: Scaillon
authors.forename: C
authors.initials: C
authors.lastname: Maurage
authors.forename: I
authors.initials: I
authors.lastname: Paquot
authors.forename: M
authors.initials: M
authors.lastname: Hermier
authors.forename: S
authors.initials: S
authors.lastname: De Napoli
authors.forename: A
authors.initials: A
authors.lastname: Dabadie
authors.forename: F
authors.initials: F
authors.lastname: Huet
authors.forename: J J
authors.initials: JJ
authors.lastname: Baudon
authors.forename: M
authors.initials: M
authors.lastname: Larchet
mesh_terms: D017668:Age of Onset; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis; D013577:Syndrome; D016896:Treatment Outcome